May is Bladder Cancer Awareness Month and EvolveImmune Therapeutics is dedicated to finding better ways to treat Bladder Cancer. Want to learn more about bladder cancer? You can find more information at the American Association for Cancer Research (AACR) website: https://lnkd.in/eHyj-v7X
EvolveImmune Therapeutics’ Post
More Relevant Posts
-
August is Appendix Cancer Awareness Month. Appendix cancer is a rare cancer diagnosed in approximately 10 people per million per year. Learn more from ACPMP - Appendix Cancer / Pseudomyxoma Peritonei Research Foundation here: https://lnkd.in/e3-7X6P9
-
-
Since today is World Lung Cancer Day I thought it would be great to acknowledge my co-authors from GeneCentric Therapeutics, Inc., Labcorp and Atrium Health Levine Cancer Institute with regards to our recent paper in Clinical Cancer Reserach where we provide further clinical evidence to support our Antifolate Predictive Response Signature (AF-PRS), which is being developed as a test to better select which therapy is best for patients with non-squamous NSCLC. https://lnkd.in/g6UmB6pC
-
-
Dealing with bladder cancer can be a difficult journey, which is why we are committed to holding discussions about advanced precision therapies and personalised patient care. Our upcoming webinar is a unique opportunity to gain valuable knowledge and understand the innovative approach to bladder cancer treatments. Highly recommend registering for the webinar to learn more about this important topic! https://lnkd.in/d63CDhnt
-
November is Lung Cancer Awareness Month. A screening can detect lung cancer early, when it is more likely to be curable. Learn more about lung cancer screening resources: https://ow.ly/9gtt50Q2nPz
-
-
Check out the announcement below from Verismo!
Verismo Therapeutics is thrilled to announce the opening of our second clinical site at MD Anderson Cancer Center for the STAR-101 (NCT05568680) Phase 1 trial that is treating ovarian cancer, mesothelioma and cholangiocarcinoma. This is another leap forward in our mission to help patients that are suffering from cancer. For more information see the full press release: https://lnkd.in/e4SgGzUc #VersimoTherapeutics #SynKIR110 #BestTeamEver #CellTherapy
-
-
LORAZEPAM TREATMENT MAY BE LINKED TO WORSE OUTCOMES FOR PANCREATIC CANCER PATIENTS https://lnkd.in/gw6HYbbB Reference: Association for Cancer Research (AACR), August 17, 2023, Lorazepam Treatment May Be Linked to Worse Outcomes for Pancreatic Cancer Patients, https://lnkd.in/gJfs7kji
-
-
🚀 Live from ASCO 2024! Our latest Daily Highlight focuses on groundbreaking advancements in GI cancer research. Discover key studies on new treatments for gastric cancer, pancreatic cancer, hepatocellular cancer, and GEP-NETs, presented by Prof Alain Hendlisz. Discover these updates.👇 For all ASCO 2024 videos, find the link in the comments! #MediMix #ASCO2024 #GICancer #OncologyInnovation
-
Bilingual Content Writer | Researcher in Oncology | Aspiring Regulatory Affairs & Clinical Research Professional
Know the latest development of #BreastCancer therapeutics in #BreastCancerAwarenessMonth!
The 2023 Cancer Statistics from the American Cancer Society highlight that #BreastCancer is still the most common cancer diagnosed among women. Even though there have been significant strides in early detection and treatment, managing metastatic tumors remains a complex issue. October marks #BreastCancerAwarenessMonth. Our aim is to emphasize the importance of continued research and to motivate the creation of innovative breast cancer treatments by showcasing the latest developments in its therapeutics. #WomensHealth #MoreThanBCAM #BreastCancerSupport
-
Yearly lung screening with low dose CT (LDCT) has proven to be effective with early detection, leading to better outcomes for patients who are at high risk for developing lung cancer. To learn, watch our video on lung cancer screening: https://lnkd.in/dfR-djt
-
-
A New Era of Targeted Cancer Therapy. Unlocking the Potential of ADCs: A New Horizon in Targeted Cancer Therapy https://lnkd.in/eKGF7qiu
A New Era of Targeted Cancer Therapy - Healthcare Communications Network
https://hcn.health
More from this author
-
EvolveImmune Therapeutics to Present New Preclinical and Translational Data...
-
EvolveImmune Therapeutics Enters into Strategic Research Collaboration with Kennedy Institute of Rheumatology
-
EvolveImmune Therapeutics Reports First Results from CRISPR-Cas9 T Cell Exhaustion Screening Platform at AACR Annual Meeting 2023